Celldex Therapeutics, Inc. · NASDAQ:CLDX
State Street Corp's stake in Celldex Therapeutics, Inc. fell to 4.20% (Schedule 13G)
Event Mar 31, 2026 · Filed May 12, 2026
State Street Corp's stake in Celldex Therapeutics, Inc. fell to 4.20%, 2,804,168 shares, as a passive investor on Mar 31, 2026. Filed May 12, 2026 (Schedule 13G).
- Stake
- 4.20%
- Shares
- 2,804,168
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| STATE STREET CORPORATION | 4.20% | 2,804,168 |
Source
Related
- Celldex Therapeutics, Inc.
- State Street Corp
- Celldex Therapeutics, Inc. shareholders
- Schedule 13G · State Street Corp · Feb 9, 2026
- Schedule 13G/A · FMR LLC · Oct 7, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Aug 14, 2026
- Schedule 13G/A · Kynam Capital Management, LP · Aug 14, 2026
- Schedule 13G/A · Bellevue Group AG · May 15, 2026
- Schedule 13G/A · Kynam Capital Management, LP · May 15, 2026